Blood pressure

BP ↓, K↑

BP ↑, K↓

BP↓ 8–13 mmHg

Spikes↓; 48% fewer

Nitrate markers↓ BP -8/−4

Tolerance: BP↓ then wanes

Sildenafil amplifies nitrate hypotension

BP↓ ~3-7 mmHg

BP↓ with omega-3

SBP/DBP↓

TG↓ +5-15 mmHg

BP↓, TG↓

BP ↓ 3-6 mmHg

DHA stronger ↓ BP

SBP/DBP ↓, HR ↓

Vasodilation, −10 mmHg

Renal flow, −29%

SBP ↓ 5-12

DBP ↓ 4-13

SBP −15 to −22

DBP −4 to −12

SBP ↓12 mmHg

DBP ↓5 mmHg

Hypertension risk ↓36%

SBP −7 to −14

DBP −14%

SBP/DBP ↓ 10/7 mmHg

DBP ↓ 4 mmHg

BP ↓ 9–15 mmHg

Stress BP ↓ ~15%

Central BP/stiffness ↓

BP ↓, NO↑

Stress BP ↓, AIx↓

BP fall reduced, +4.5

SBP/DBP lowered, -7 to -8

Standing BP raised, +5.9

SBP −5–7 mmHg

DBP lowered

BP -11.2 mmHg

BP decreased significantly

BP lowered, safe

Blood pressure ↓

MAP −10 mmHg

SBP/DBP ↓ ~6-13

Metabolic markers ↓

SBP/DBP ↓ ~7 mmHg

Dose-dependent BP ↓

BP ↓5-10 mmHg

LDL ↓22-24%

Diastolic BP -4.8 mmHg

Home BP -1.8/-1.5 mmHg

SBP ↓3–7 mmHg

BP meds ↓50%

Clinic & ambulatory BP ↓

SBP −7.2 mmHg

DBP −4.7 mmHg

BP ↓ SBP -14

BP ↓ SBP/DBP

Arterial stiffness ↓

SBP −5.6, DBP −2.8

Renin activity ↓1.17

BP −8 mmHg

Aortic BP −10.4

BP lowered

BP - significant

BP decreased

BP slight edge

SBP −7 mmHg

24-h BP down

DBP lower

Arterial hemodynamics improved

BP down: -25/-11/-16

Fibrinolysis improved